Medical Research & Innovations

The molecule behind a booming anti-aging supplement market didn’t decline with age in the blood of 1,068 adults, but it was lower in one group of people

The molecule behind a booming anti-aging supplement market didn’t decline with age in the blood of 1,068 adults, but it was lower in one group of people

NAD supplements such as NMN and NR are sold on a simple story: levels of this molecule fall as we age, so topping them up should slow aging. Most of the evidence for that decline comes from animal tissues. Researchers at Vilnius University measured NAD in the blood of 1,068 adults, using 1,340 dried blood samples, to see whether the same drop shows up in people.

It did not. In healthy men, blood NAD stayed steady across the ages in the study. In healthy women it rose slightly with age, a small but statistically significant increase.

Where NAD did fall was in people with cardiovascular disease. Their levels were lower than in people without it, and the gap was clearest in people with high blood pressure.

In other words, in this study blood NAD tracked heart and blood vessel health, not birthdays.

NAD, short for nicotinamide adenine dinucleotide, is a molecule every cell uses to turn food into energy and to repair DNA. Over the past decade it has become one of the best-known names in the longevity business, with NAD precursors sold as capsules, powders and IV drips.

The pitch rests largely on animal work. Studies in mice and other animals found NAD dropping in tissues such as muscle and liver with age, and raising it improved some signs of aging in those animals. Whether people lose NAD the same way has been much less clear.

The Vilnius team, led by Dalius Ratautas, used dried blood spots, a drop of blood dried onto a card. That made it practical to collect samples from a large group and, for some people, to measure more than once.

Ratautas has described the finding as a challenge to the prevailing narrative that NAD simply declines with age. The question it raises instead, he said, is: “could NAD levels tell us something about cardiovascular health?”

The link with high blood pressure is the most intriguing part. It does not show that low NAD causes heart disease. Illness, medication and lifestyle could all lower NAD, or something else could drive both. The researchers say the next step is to test whether blood NAD can help predict cardiovascular risk.

Heart and metabolic health keep turning out to matter for aging more than any single molecule. We recently covered how healthy diets were linked to slower biological aging, and how sleep ties into brain health, diabetes, heart disease and stroke.

There is an important catch. In a commentary on the study, Stephen Gardell and Joseph Baur point out that most NAD in whole blood sits inside red blood cells. Blood levels may not reflect what is happening in muscle, liver or brain, the tissues where animal studies found the decline.

So the study does not prove that NAD never falls with age in human tissues. It shows that a simple blood test does not show the drop that supplement marketing often implies.

It also says nothing about whether NAD supplements work. The study did not give anyone supplements, and it was not designed to test them. Anyone taking them for a heart condition or high blood pressure should talk to their doctor rather than rely on the pills.

Other limits: the study is observational, it measured NAD in whole blood only, and the results come from adults in one country.

Source

Ratautas D, Dagys M, Ratautė K, Stakelytė D, et al. “Whole-blood NAD levels track cardiovascular disease but not chronological age.” Nature Metabolism, 2026.
DOI: 10.1038/s42255-026-01660-3